Bio-Rad Laboratories, Inc.

582 articles with Bio-Rad Laboratories, Inc.

• Bio-Rad to Participate in Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference

  2/17/2023

  Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced that the company’s management will participate in a fireside chat event during Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference on Thursday, March 2, 2023, at 11:45 AM Eastern Time.

• Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results

  2/16/2023

  Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced financial results for the fourth quarter and full year ended December 31, 2022.

• Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023

  1/6/2023

  Bio-Rad Laboratories, Inc. will report its financial results for the fourth quarter and full year 2022 on Thursday, February 16, 2023, following the close of the market.

• Bio-Rad to Present Company Overview at J.P. Morgan 41st Annual Healthcare Conference

  1/4/2023

  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 4:30 p.m. Pacific Time.

• Bio-Rad and NuProbe Enter into an Exclusive Licensing Agreement for Digital PCR Applications

  11/7/2022

  Bio-Rad Laboratories, Inc.,  (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, and NuProbe USA, a genomics and molecular diagnostics company, today announced the signing of a licensing and product development agreement.

• Bio-Rad To Participate in Fireside Chat During Credit Suisse’s 31st Annual Healthcare Conference

  10/31/2022

  Bio-Rad Laboratories, Inc. today announced that the company’s management will participate in a Fireside Chat event during the Credit Suisse 31st Annual Healthcare Conference on Tuesday, November 8, 2022, at 11:00 AM (PST).

• Bio-Rad Reports Third-Quarter 2022 Financial Results

  10/27/2022

  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the third quarter ended September 30, 2022.

• Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022

  10/17/2022

  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) will report its financial results for the third quarter of 2022 on Thursday, October 27, 2022, following the close of the market.

• Bio-Rad Acquires Curiosity Diagnostics

  8/3/2022

  Bio-Rad Laboratories, Inc. announced that it has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A., a Warsaw, Poland, for a total consideration of up to $170 million, consisting of approximately $100 million in cash, and up to $70 million in future milestone payments.

• Bio-Rad Reports Second-Quarter 2022 Financial Results

  7/28/2022

  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the second quarter ended June 30, 2022.

• Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022

  7/18/2022

  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the second quarter of 2022 on Thursday, July 28, 2022, following the close of the market.

• Bio-Rad Publishes Corporate Sustainability Report

  6/27/2022

  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today released its inaugural corporate sustainability report.

• Bio-Rad Reports First-Quarter 2022 Financial Results

  4/28/2022

  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31, 2022.

• Bio-Rad to Report First-Quarter Financial Results, Thursday, April 28, 2022

  4/18/2022

  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the first quarter 2022 on Thursday, April 28, 2022, following the close of the market.

• Bio-Rad Announces Closing of $1.2 Billion Aggregate Senior Notes Offering

  3/2/2022

  Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced the closing of its underwritten public offering of $1.2 billion aggregate principal amount of the following notes, each issued at par.

• Bio-Rad Presents Growth Strategy and Acceleration of Financial Targets at Investor Day

  2/25/2022

  Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, is hosting an in-person investor day beginning at 10:30 a.m. EST in New York City.

• Bio-Rad Reports Fourth-Quarter and Full-Year 2021 Financial Results

  2/10/2022

  Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced financial results for the fourth quarter and year ended December 31, 2021.

• Bio-Rad to Host Investor Day on February 25

  2/2/2022

  Bio-Rad Laboratories, Inc. announced today that it will host an in-person investor day in New York City on Friday, February 25, 2022, at 10:30 a.m. EST. A live webcast will also be available.

• Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022

  1/25/2022

  Bio-Rad Laboratories, Inc. will report financial results for the fourth quarter and full year 2021 on Thursday, February 10, 2022, following the close of the market.

• Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11

  1/5/2022

  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO; Andrew Last, Executive Vice President and COO; and Ilan Daskal, Executive Vice President and CFO will participate in a virtual Fireside Chat during the 40th Annual J.P. Morgan Healthcare Conference.